Immunoreactivity of thymosin beta 4 in human foetal and adult genitourinary tract

European Journal of Histochemistry

Volumn 54, Issue 4, 2010, Pages 193-196

  Nemolato, S ^a   Cabras, T ^a   Fanari, M U ^a   Cau, F ^a   Fanni, D ^a   Gerosa, C ^a   Manconi, B ^a   Messana, I ^a   Castagnola, M ^b   Faa, G ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Development; Genitourinary tract; Thymosin 4

Indexed keywords

EID: 78249274896     PISSN: 1121760X     EISSN: None     Source Type: Journal    
DOI: 10.4081/ejh.2010.e43     Document Type: Article

References (27)

1. Mannherz HG, Hannappel E. The beta-thymosins: intracellular and extracellular activities of a versatile actin binding protein family. Cell Motil Cytoskeleton 2009; 66:839-51.
2. Safer D, Golla R, Nachmias VT. Isolation of a 5-kilodalton actin-sequestering peptide from human blood platelets. PNAS USA 1990;87:2536-40.
3. Dominguez R. The β-Thymosin/WH2 fold. Multifunctionality and structure. Ann N Y Acad Sci 2007;1112:86-94.
4. Paulussen M, Landuyt B, Schoofs L, Luyten W, Arckens L. Thymosin beta 4 mRNA and peptide expression in phagocytic cells of different mouse tissues. Peptides 2009; 30:1822-32.
5. Young JD, Lawrence AJ, MacLean AG, Leung BP, McInnes IB, Canas B et al. Thymosin beta-4 sulfoxide is an antiinflammatory agent generated by monocytes in the presence of glucocorticoids. Nat Med 1999;5:1424-7.
6. Wessels A, Perez-Pomares JM. The epicardium and epicardially derived cells (EPDCs) as cardiac stem cells. Anat Rec A Discov Mol Cell Evol Biol 2004;276:43-57.
7. Smart N, Rossdeutsch A, Riley PR. Thymosin β4 and angiogenesis: modes of action and therapeutic potential. Angio - genesis 2007;10:229-41.
8. Sosne G, Szliter EA, Barrett R, Kernacki KA, Kleinman H, Hazlett LD. Thymosin beta-4 promotes corneal wound healing and decreases inflammation in vivo following alkali injury. Exp Eye Res 2002;74:293-9.
9. Nemolato S, Messana I, Cabras T, Manconi B, Inzitari R, Fanali C et al. Thymosin beta (4) and beta (10) levels in preterm newborn oral cavity and foetal salivary glands evidence a switch of secretion during foetal development. PLoS One 2009; 4:e5109.
10. von Kodolitsch Y, Ito WD, Franzen O, Lund GK, Koschyk DH, Meinertz T. Coronary artery anomalies Part I: recent insights from molecular embryology. Z Kardiol 2004;93:929-37.
11. Lin SC, Morrison-Bogorad M. Develop - mental expression of mRNAs encoding thymosins beta-4 and beta 10 in rat brain and other tissues. J Mol Neurosci 1990;2:35-44.
12. Guinobert I, Viltard M, Piquemal D, Elalouf JM, Marti J, Lelièvre-Pégorier M. Identification of differentially expressed genes between fetal and adult mouse kidney: candidate gene in kidney development. Nephron Physiol 2006;102:81-91.
13. Mora CA, Baumann CA, Paino JE, Goldstein AL, Badamchian M. Biodi - stribution of synthetic thymosin beta 4 in the serum, urine, and major organs of mice. Int J Immunopharmacol 1997;19:1-8.
14. Hall AK. Differential expression of thymosin genes in human tumors and in developing human kidney. Int J Cancer 1991;48:672-7.
15. Ma LJ, Fogo AB. PAI-1 and kidney fibrosis. Front Biosci 2009;14: 2028-41.
16. Hall AK, Aten R, Behrman HR. Thymosin gene expression is modulated by pregnant mare's serum gonadotropin, human chorionic gonadotropin, and prostaglandin F2 alpha in the immature rat ovary. Endo - crinology 1991;128:951-7.
17. Hall AK, Aten R, Behrman HR. Differential modulation of thymosin genes in the immature rat ovary by gonadotropins. Mol Cell Endocrinol 1991;79:37-43.
18. Wise TH. Developmental changes of thymosin alpha 1 and beta 4 in male and male castrated pigs: modulation by testosterone and human chorionic gonadoropin. Biol Reprod 1992;46:892-7.
19. Iguchi K, Ito M, Usui S, Mizokami A, Namiki M, Hirano K. Downregolation of thymosin beta 4 expression by androgen in prostate cancer LNCaP cells. J Androl 2008; 29:207-12.
20. Ito M, Iguchi K, Usui S, Hirano K. Overexpression of thymosin beta 4 increases pseudopodia formation in LNCaP prostate cancer cells. Biol Pharm Bull 2009;32:1101-4.
21. Nemolato S, Cabras T, Fanari MU, Cau F, Fraschini M, Manconi B, et al. Thymosin beta 4 expression in normal skin, colon mucosa and in tumor infiltrating mast cells. Eur J Histochem 2010;54:e3.
22. Kannan L, Rath NC, Liyanage R, Lay JO. Identification and characterization of thymosin β-4 in chicken macrophages using whole cell MALDI-TOF. Ann N Y Acad Sci 2007;1112:425-34.
23. Nemolato S, Cabras T, Cau F, Fanari MU, Fanni D, Manconi B, et al. Different Thymosin Beta 4 Immunoreactivity in Foetal and Adult Gastrointestinal Tract. PLoS One 2010;5: e9111.
24. Wang WS, Chen PM, Su Y. Colorectal carcinoma: from tumorigenesis to treatment. Cell Mol Life Sci 2006;63:663-71.
25. Otto AM, Muller CSG, Huff T, Hannappel E. Chemotherapeutic drugs change actin skeleton organization and the expression of beta thymosins in human breast cancer cells. J Cancer Res Clin Oncol 2002;128: 247-56.
26. Ji P, Diederichs S, Wang W, Boing S, Metzger R, Schneider PM, et al. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 2003;22:8031-41.
27. Choi SY, Kim DK, Eun B, Kim K, Sun W, Kim H. Anti-apoptotic function of thymosin beta in developing chick spinal motoneurons. Biochim Biophys Res Commun 2006;346:872-8.